ChemoCentryx Inc (NASDAQ:CCXI)

BATS BZX Real-Time Price
 +0.05 / +0.57%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer. It was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

Contact Information

ChemoCentryx, Inc.
850 Maude Avenue
Mountain View California 94043
P:(650) 210-2900
Investor Relations:



Individual stakeholders48.42%
Other institutional38.96%
Mutual fund holders24.79%

Top Executives

Thomas J. SchallChairman, President & Chief Executive Officer
Susan M. KanayaCFO, Secretary & Head-Investor Relations
Petrus BekkerSenior Vice President-Medical & Clinical Affairs
Juan C. JaenChief Scientific Officer & SVP-Drug Discovery
Anne-Marie S. DuliegeChief Strategic Development Officer & Executive VP

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.